FIXED FIVE-YEAR COHORT AUDIT
近五年文献重新检索与对照
旧查询复现与严格 v3 为主比较;历史库存和广召回仅用于解释差异与检查漏检。
固定日期2021-07-29 至 2026-07-29
入排版本oncology-definitive-rct-km-v3
并集论文20925
批次键five-year-20210729-20260729-v1
四个独立队列
数字为批次中保存的原始 PMID 数,不会随着日常监测改变。
集合关系
交集和差集均按 PMID 精确计算;DOI 只用于明细核对。
严格查询未命中、但影子组经 v3 筛选后合格
166 篇
KM 证据
仅检查 v3 元数据合格论文,不运行曲线数字化。
论文明细
共 18282 篇;可组合筛选集合关系、入排结果和 KM 证据。
| 论文 | 队列 | 集合关系 | v3 入排 | KM 证据 |
|---|---|---|---|---|
| Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial. PMID 40593475 · Nat Commun · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
B
|
仅广召回影子组 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study. PMID 40593014 · Sci Rep · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
B
|
仅广召回影子组 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab. PMID 40591171 · J Patient Rep Outcomes · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial†. PMID 40578313 · Eur J Cardiothorac Surg · 2025-Jul-01 The report is a secondary analysis of a Phase III RCT comparing surgical techniques, not a drug intervention. The primary endpoint is N2 upstaging, a categorical pathological endpoint, not a time-to-event efficacy endpoint (OS, PFS, etc.). Therefore, it does not meet the core criteria for inclusion in this oncology KM digitization cohort. |
H
L
B
|
旧查询独有 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Evaluating the Efficacy of MamaLift Plus Digital Therapeutic Mobile App for Postpartum Depression (SuMMER): Randomized, Placebo-Controlled Pivotal Trial. PMID 40549508 · J Med Internet Res · 2025-Jul-01 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse. PMID 40455046 · JNCI Cancer Spectr · 2025-Jul-01 The report is a secondary analysis of pooled phase 2/3 trial data, not the primary result report of the phase III/IIIb or phase II/III trial itself. Furthermore, the specific drug intervention(s) are not identified in the provided record, preventing confirmation of a drug-containing intervention. |
H
L
S
B
|
旧组与严格 v3 交集 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis. PMID 40451185 · JAMA Oncol · 2025-Jul-01 记录类型属于综述、Meta 分析、社论、评论、病例或指南。 |
H
S
B
|
严格 v3 独有 | excludedexcluded_publication_type | pending 0 Figure · 0 Panel · risk - |
| Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial. PMID 40434784 · JAMA Surg · 2025-Jul-01 Study is an oncology Phase 3 randomized trial with time-to-event endpoints and original results, but the interventions (CRT-TEM vs TME) do not meet the requirement for a drug-containing intervention as defined by a specific pharmaceutical agent vs another agent or placebo. |
H
L
S
B
|
旧组与严格 v3 交集 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Association of Hospitalizations With Randomized Glycemia-Lowering Treatment in GRADE. PMID 40424051 · Diabetes Care · 2025-Jul-01 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up. PMID 40420404 · Hum Reprod · 2025-Jul-01 干预为非药物单独策略,未满足药物干预要求。 |
B
|
仅广召回影子组 | excludednon_drug_intervention | pending 0 Figure · 0 Panel · risk - |
| Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trial. PMID 40411761 · Eur J Cardiothorac Surg · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial. PMID 40402484 · JAMA Otolaryngol Head Neck Surg · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
S
B
|
旧组与严格 v3 交集 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial. PMID 40388916 · JAMA · 2025-Jul-01 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial. PMID 40372727 · JAMA Oncol · 2025-Jul-01 仅有 Phase I/II 证据,未达到确证性随机试验标准。 |
B
|
仅广召回影子组 | excludedearly_phase_only | pending 0 Figure · 0 Panel · risk - |
| Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial. PMID 40354061 · JAMA Neurol · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial. PMID 40332898 · JAMA Dermatol · 2025-Jul-01 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents: A Phase 3 Randomized Clinical Trial. PMID 40305055 · JAMA Dermatol · 2025-Jul-01 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study. PMID 40300087 · Clin Cancer Res · 2025-Jul-01 仅有 Phase I/II 证据,未达到确证性随机试验标准。 |
B
|
仅广召回影子组 | excludedearly_phase_only | pending 0 Figure · 0 Panel · risk - |
| Application of Neoadjuvant Docetaxel plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial. PMID 40260648 · Clin Cancer Res · 2025-Jul-01 仅有 Phase I/II 证据,未达到确证性随机试验标准。 |
B
|
仅广召回影子组 | excludedearly_phase_only | pending 0 Figure · 0 Panel · risk - |
| Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program. PMID 40243198 · Cancer Prev Res (Phila) · 2025-Jul-01 While the study meets several criteria (randomized, phase III, human, time-to-event endpoint), it is excluded because it is not a therapeutic trial for an existing malignant neoplasm. It is a cancer prevention trial in a diabetes population, and the intervention is not a drug-containing regimen for treating diagnosed cancer. |
H
L
B
|
旧查询独有 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTET. PMID 40178246 · J Hypertens · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial. PMID 40139716 · Rheumatology (Oxford) · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
B
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| A minimal clinically important difference for the sleep inertia visual analog scale in idiopathic hypersomnia. PMID 40135693 · J Clin Sleep Med · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
L
|
旧查询独有 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Effect of adjuvant chemotherapy with toad venom injection in the treatment of intermediate and advanced colon cancer and its effect on cellular immunity, PTEN, and PI3k. PMID 39964699 · Anticancer Drugs · 2025-Jul-01 The record is a randomized oncology trial with a drug intervention and reports original results, but it lacks the required primary or key secondary time-to-event efficacy endpoint (e.g., OS, PFS, DFS, etc.) as a formal, quantitative outcome. The study reports a 1-year survival rate as a simple proportion without Kaplan-Meier analysis or hazard ratio, which does not meet the time-to-event criterion. |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Long-term survival from a randomized controlled trial of lobectomy by video-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer. PMID 39873729 · Eur J Cardiothorac Surg · 2025-Jul-01 The study is a randomized, oncology trial with time-to-event endpoints and is an original result report. However, it compares two surgical techniques (VATS vs. thoracotomy) and does not involve a drug-containing intervention, which is a required criterion. |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Three-year Survival Outcomes of Patients With Enhanced Recovery After Surgery Versus Conventional Care in Laparoscopic Distal Gastrectomy: The GISSG1901 Randomized Clinical Trial. PMID 39660451 · Ann Surg · 2025-Jul-01 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
B
|
仅广召回影子组 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Identification and Categorization of Technical Errors and Hazard Zones of Robotic Versus Laparoscopic Total Gastrectomy for Gastric Cancer: A Single-center Prospective Randomized Controlled Study. PMID 39513271 · Ann Surg · 2025-Jul-01 干预为非药物单独策略,未满足药物干预要求。 |
B
|
仅广召回影子组 | excludednon_drug_intervention | pending 0 Figure · 0 Panel · risk - |
| Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter Trial. PMID 39360422 · Ann Surg · 2025-Jul-01 The study is a randomized trial in esophageal cancer (oncology, human), but the intervention is purely procedural (analgesia techniques), not a drug-containing intervention. The primary outcome is quality of recovery (QoR-40), a patient-reported outcome measure, not a time-to-event efficacy endpoint. Secondary outcomes include quality of life and complications, but no time-to-event efficacy endpoints like OS, PFS, DFS, EFS, RFS, TTP, or time-to-event analyses (Kaplan-Meier, HR) are reported. Therefore, it does not meet the required criteria for inclusion. |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Emerging Role of Multiparametric MRI in the Staging of Bladder Cancer: Insights From the BladderPath Trial. PMID 40861675 · Cureus · 2025-Jul 记录类型属于综述、Meta 分析、社论、评论、病例或指南。 |
B
|
仅广召回影子组 | excludedexcluded_publication_type | pending 0 Figure · 0 Panel · risk - |
| Effects of an Afrocentric Sexual Health Education Curriculum for Medical, Nursing, and Midwifery Students in Tanzania: A Single-Blinded Randomized Controlled Phase 3 Trial. PMID 40789797 · Arch Sex Behav · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Effects of the "Internet +" nursing model based on user profiling on postoperative recovery in breast cancer: A prospective randomized controlled clinical trial. PMID 40786863 · Int J Nurs Sci · 2025-Jul The study is a randomized, prospective, human oncology trial with primary results. However, it is excluded because it does not meet the core eligibility criteria: it is not reported as a Phase III/IIIb or Phase II/III trial, the intervention is a non-drug 'Internet+' nursing model, and the primary endpoints are quality-of-life and symptom scores (FOP-Q-SF, FCRI-SF, C-PTGI, FACT-B), not a time-to-event efficacy endpoint like OS, PFS, or DFS. |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial. PMID 40755226 · Health Technol Assess · 2025-Jul The trial is an oncology, human, randomized, Phase III drug intervention with original results, but it fails the time-to-event endpoint criterion. The primary outcome is a patient-reported fatigue score (FACT-Fatigue), not OS, PFS, DFS, EFS, RFS, TTP, or any other time-to-event measure. Survival is mentioned only as a secondary outcome with no time-to-event analysis details. |
H
L
S
B
|
旧组与严格 v3 交集 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial. PMID 40741224 · EClinicalMedicine · 2025-Jul 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
|
仅历史库存 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Outcomes of posterior lamellar tarsal rotation vs bilamellar tarsal rotation for trachomatous trichiasis. PMID 40737343 · PLoS Negl Trop Dis · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial. PMID 40736776 · Allergy Asthma Immunol Res · 2025-Jul 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
|
仅历史库存 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Shufeng Jiedu Granule against mild COVID-19: Protocol of the randomized, double-blind, placebo-controlled, multi-center heal-COVID phase III study. PMID 40734912 · Chin Herb Med · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
|
仅历史库存 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. PMID 40728026 · Pediatr Pulmonol · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia. PMID 40717666 · Alzheimers Dement · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Empirical Derivation and Prediction of Treatment Trajectories in Harmonized AUD Clinical Trial Datasets. PMID 40700031 · Addict Biol · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
|
仅历史库存 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| An overview of randomized phase III clinical trials of cancer nanomedicines. PMID 40697515 · Cancer Pathog Ther · 2025-Jul 记录类型属于综述、Meta 分析、社论、评论、病例或指南。 |
H
S
B
|
严格 v3 独有 | excludedexcluded_publication_type | pending 0 Figure · 0 Panel · risk - |
| Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials. PMID 40690519 · PLoS Med · 2025-Jul The record describes an observational analysis (target trial emulation) benchmarked against two existing randomized trials (B-31 and N9831). It is not an original formal-result report of a Phase III/IIIb or Phase II/III randomized trial with a drug-containing intervention and a time-to-event efficacy endpoint. While it discusses and cites Phase III trials, the report itself does not present the results of such a trial. |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Group-based interventions to reduce gambling involvement among male football fans: a synopsis of findings from a feasibility study. PMID 40690427 · Public Health Res (Southampt) · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
|
仅历史库存 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial. PMID 40686671 · EClinicalMedicine · 2025-Jul 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
|
仅历史库存 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical Trials. PMID 40672760 · Open Forum Infect Dis · 2025-Jul 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 |
H
|
仅历史库存 | excludedpost_hoc_or_secondary_analysis | pending 0 Figure · 0 Panel · risk - |
| Donanemab exposure-response in early symptomatic Alzheimer's disease. PMID 40667684 · Alzheimers Dement · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial. PMID 40663622 · Circ Cardiovasc Interv · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| Association of ATP-binding cassette transporter genomic alterations and expressions with patient survival in breast and prostate cancer. PMID 40641097 · Physiol Rep · 2025-Jul The record is a retrospective biomarker/prognostic analysis using public genomic datasets. It is not an original report of a Phase III/IIIb or Phase II/III randomized trial with a drug intervention and a primary time-to-event efficacy endpoint. |
H
S
B
|
严格 v3 独有 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Feasibility Randomised Controlled Trial of a New Digital Intervention ('FRAME') to Promote Resilience in Women Treated for Primary Breast Cancer. PMID 40634264 · Psychooncology · 2025-Jul The study is a randomized, human, oncology (breast cancer) feasibility trial, but it is not eligible for the cohort because it is not a Phase III/IIIb or definitive Phase II/III trial, it does not involve a drug-containing intervention (it's a digital/CBT intervention), and it does not report a primary or key secondary time-to-event efficacy endpoint (outcomes are acceptability, feasibility, interpretation bias, resilience, mood, and quality of life). |
B
|
仅广召回影子组 | excludedmodel_adjudicated_excluded | pending 0 Figure · 0 Panel · risk - |
| Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS-STAT2 Cohort. PMID 40631687 · Eur J Neurol · 2025-Jul 未发现恶性肿瘤人群证据。 |
H
L
|
旧查询独有 | excludednon_oncology | pending 0 Figure · 0 Panel · risk - |
| VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML. PMID 40629154 · Ann Hematol · 2025-Jul 仅有 Phase I/II 证据,未达到确证性随机试验标准。 |
B
|
仅广召回影子组 | excludedearly_phase_only | pending 0 Figure · 0 Panel · risk - |